ProfileGDS5822 / ILMN_3115162
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 84% 79% 79% 87% 81% 86% 79% 84% 78% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1216.384
GSM1276600PDAC Late Ablation Control 2134.379
GSM1276601PDAC Late Ablation Control 3182.479
GSM1276602PDAC Late Ablation 1306.887
GSM1276603PDAC Late Ablation 2163.981
GSM1276604PDAC Late Ablation 3310.286
GSM1303940PDAC Late Ablation_anti-CTLA4 1119.979
GSM1303941PDAC Late Ablation_anti-CTLA4 2294.784
GSM1303942PDAC Late Ablation_anti-CTLA4 3147.278